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A B S T R A C T
A systematic review of longitudinal studies suggests that intimate partner violence (IPV) is associated with
reduced contraceptive use, but most included studies were limited to two time points. We used seven waves of
data from the Rakai Community Cohort Study in Rakai, Uganda to estimate the effect of prior year IPV at one
visit on women's current contraceptive use at the following visit. We used inverse probability of treatment-
weighted marginal structural models (MSMs) to estimate the relative risk of current contraceptive use comparing
women who were exposed to emotional, physical, and/or sexual IPV during the year prior to interview to those
who were not. We accounted for time-fixed and time-varying confounders and prior IPV and adjusted standard
errors for repeated measures within individuals. The analysis included 7923 women interviewed between 2001
and 2013. In the weighted MSMs, women who experienced any form of prior year IPV were 20% less likely to use
condoms at last sex than women who had not (95% CI: 0.12, 0.26). We did not find evidence that IPV affects
current use of modern contraception (RR: 0.99; 95% CI: 0.95, 1.03); however, current use of a partner-dependent
method was 27% lower among women who reported any form of prior-year IPV compared to women who had
not (95% CI: 0.20, 0.33). Women who experienced prior-year IPV were less likely to use condoms and other
forms of contraception that required negotiation with their male partners and more likely to use contraception
that they could hide from their male partners. Longitudinal studies in Rakai and elsewhere have found that
women who experience IPV have a higher rate of HIV than women who do not. Our finding that women who
experience IPV are less likely to use condoms may help explain the relation between IPV and HIV.
1. Introduction
The World Health Organization defines intimate partner violence
(IPV) as physical, sexual, or emotional abuse by a current or former
partner (Krug et al., 2002). Research indicates that IPV is associated
with adverse sexual and reproductive health (SRH) outcomes, including
unintended pregnancy (Christina C Pallitto, Campbell, & O'Campo,
2005; Christina C. Pallitto et al., 2013), repeat abortion (Hall et al.,
2014), and HIV (Kouyoumdjian et al., 2013a,b; Li et al., 2014), but the
causal mechanisms underlying these associations are poorly understood
(Jewkes, 2015). In 2011, the estimated prevalence of HIV among adults
in Uganda was 7% (Ministry of Health/Uganda & ICF International,
2012), recent estimates of the prevalence of HIV in Rakai range from 14
to 42% (Chang et al., 2016). The Uganda Demographic and Health
surveys found that, between 2006 and 2011, the use of modern con-
traception increased from 18% to 26% among Ugandan women of re-
productive age (WRA); in Rakai district, the use of modern contra-
ception increased from an estimated 33%–42% over the same period
(Brahmbhatt et al., 2014). Longitudinal studies in Rakai
(Kouyoumdjian et al., 2013a,b) and elsewhere (Li et al., 2014) have
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found that women who experience IPV are at a higher risk of incident
HIV infection than women who do not. The relation between IPV and
adverse SRH outcomes, including HIV, may be mediated by the effect of
IPV on women's contraceptive use; a recent systematic review suggests
that women who experience IPV are less likely to use condoms than
women who do not (Maxwell et al., 2015). Previous studies of the re-
lation between IPV and contraceptive use are based on cross-sectional
data or on longitudinal data with limited follow-up (Maxwell et al.,
2015). This study builds on prior work by applying marginal structural
models (MSMs) to data from the Rakai Community Cohort Study
(RCCS) to estimate the effect of IPV on women's contraceptive use. The
RCCS is one of few population-level cohorts to record multiple mea-
sures of IPV and contraceptive use over time.
In this study, we used data from the RCSS to address three chal-
lenges to estimating the effect of IPV on women's contraceptive use.
First, we will never create a controlled trial where we randomize
women to experience IPV. However, women who experience IPV and
those who do not likely differ in ways that affect their contraceptive
Fig. 1. Selection of study sample.
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use. Prior longitudinal studies have accounted for measured con-
founding of the relation between IPV and contraceptive use through
standard multivariable regression adjustment. However, potential
confounders of the relation between IPV and contraceptive use may also
be affected by the incidence of IPV. For example, research indicates that
incident pregnancy may be associated with an increase in IPV (Gee
et al., 2009; Miller et al., 2010; Miller et al., 2007); and IPV is thought
to affect the probability of subsequent pregnancy (Hall et al., 2014;
Miller et al., 2014; Stephenson et al., 2013). Therefore, gravidity and
parity are potential time-varying confounders that are affected by prior
exposure to IPV. Using standard regression adjustment to control for
these types of covariates may bias estimates (Maxwell et al., 2015).
Unlike the standard regression approach, inverse probability of treat-
ment (IPT)-weighted-MSMs can be applied to longitudinal data to ac-
count for time varying confounders affected by prior exposure without
adjusting for the mediating effect of these confounders (Hernán et al.,
2001; Robins et al., 2000). Second, research suggests that the frequency
of IPV may increase with subsequent pregnancies (Gee et al., 2009) and
that the frequency and duration of abuse may increase the effects on
women's health (Houry et al., 2006; Maxwell et al., 2015; Pico-Alfonso
et al., 2006). Therefore, studies that measure exposure to IPV at one
time-point may produce a biased estimate of the effect of IPV on con-
traceptive use. We assessed whether there was a dose-response relation
between the duration of IPV, measured by the proportion of visits that
women reported prior-year IPV, and women's contraceptive use. Lastly,
a systematic review of the relation between IPV and women's contra-
ceptive use indicated that the grouping of contraceptive methods could
be an important source of heterogeneity in the pooled estimates
(Maxwell et al., 2015). In this analysis, we examined the relation be-
tween IPV and different classifications of contraceptive use to de-
termine how the relation differs across these categories. By addressing
these important limitations to the extant literature, this analysis fur-
thers our understanding of the effect of IPV on women's contraceptive
use.
2. Materials and methods
2.1. Study dataset
This study uses data from the RCCS, a community-based, open co-
hort in Rakai, Uganda administered by the Uganda Ministry of Health,
Makerere University, Johns Hopkins Bloomberg School of Public
Health, and Columbia University. The entire population of consenting
adults aged 15–49 years has been enrolled and followed annually in an
open cohort since 1994, with average retention rates over 90%
(Kouyoumdjian et al., 2013b). Detailed information regarding the
sample and study design are available elsewhere (Sewankambo et al.,
1994; Wawer et al., 1999). Questions on IPV were first added to the
RCCS annual surveys in 2000. At each survey wave, participants were
asked whether they had experienced emotional, physical, or sexual IPV
during the prior year. IPV-related questions were based on the modified
Conflict Tactics Scale (Straus, Hamby, Boney-McCoy and Sugarman,
1996) and female interviewers only asked about women's experience of
IPV if they were able to speak with respondents without other adults
present, in keeping with the World Health Organization's re-
commendations for the protection of participants in interpersonal
Table 1
Characteristics of analysis sample recorded at first follow-up survey, stratified by prior year exposure to intimate partner violence, from the Rakai Community Cohort
Study survey waves 8–15 conducted between 2001 and 2013 (N=8695).
Any IPV Emotional IPV Physical IPV Sexual IPV
IPV No IPV IPV No IPV IPV No IPV IPV No IPV
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
2492 (29%) 6197 (71%) 2126 (24%) 6563 (76%) 1573 (18%) 7116 (82%) 1222 (14%) 7467 (86%)
Education attainment
No formal education 192 (8%) 447 (7%) 165 (8%) 474 (7%) 118 (8%) 521 (7%) 82 (7%) 557 (7%)
Primary 1622 (65%) 3800 (61%) 1396 (66%) 4026 (61%) 1044 (66%) 4378 (62%) 806 (66%) 4616 (62%)
Secondary or higher 677 (27%) 1948 (31%) 564 (27%) 2061 (31%) 411 (26%) 2214 (31%) 333 (27%) 2292 (31%)
Missing 1 (0%) 2 (0%) 1 (0%) 2 (0%) 0 (0%) 3 (0%) 1 (0%) 2 (0%)
Relationship status
Husband – monogamous 1028 (41%) 2388 (39%) 881 (41%) 2535 (39%) 639 (41%) 2777 (39%) 515 (42%) 2901 (39%)
Husband - polygamous 480 (19%) 979 (16%) 410 (19%) 1049 (16%) 288 (18%) 1171 (16%) 234 (19%) 1225 (16%)
Boyfriend 427 (17%) 1894 (31%) 339 (16%) 1982 (30%) 252 (16%) 2069 (29%) 219 (18%) 2102 (28%)
Consensual partner 531 (21%) 900 (15%) 476 (22%) 955 (15%) 373 (24%) 1058 (15%) 236 (19%) 1195 (16%)
Occupation
Work at homea 1738 (70%) 4064 (66%) 1500 (71%) 4302 (66%) 1103 (70%) 4699 (66%) 823 (67%) 4979 (67%)
Work outside home 741 (30%) 2098 (34%) 614 (29%) 2225 (34%) 461 (29%) 2378 (33%) 391 (32%) 2448 (33%)
Sex partners last year
None 14 (1%) 202 (3%) 13 (1%) 203 (3%) 3 (0%) 213 (3%) 3 (0%) 213 (3%)
1 2307 (93%) 5778 (93%) 1973 (93%) 6112 (93%) 1435 (91%) 6650 (93%) 1116 (91%) 6969 (93%)
>1 171 (7%) 217 (4%) 140 (7%) 248 (4%) 135 (9%) 253 (4%) 103 (8%) 285 (4%)
Condom use at last sex
No 1978 (79%) 4600 (74%) 1686 (79%) 4892 (75%) 1231 (78%) 5347 (75%) 958 (78%) 5620 (75%)
Yes 279 (11%) 1157 (19%) 229 (11%) 1207 (18%) 176 (11%) 1260 (18%) 155 (13%) 1281 (17%)
No partner last year 235 (9%) 440 (7%) 211 (10%) 464 (7%) 166 (11%) 509 (7%) 109 (9%) 566 (8%)
Current use of any contraceptionb
No 1250 (50%) 3014 (49%) 1089 (51%) 3175 (48%) 782 (50%) 3482 (49%) 592 (48%) 3672 (49%)
Yes 850 (34%) 2262 (37%) 718 (34%) 2394 (36%) 530 (34%) 2582 (36%) 439 (36%) 2673 (36%)
Not asked because currently pregnant 392 (16%) 921 (15%) 319 (15%) 994 (15%) 261 (17%) 1052 (15%) 191 (16%) 1122 (15%)
IPV= intimate partner violence.
a Includes agricultural work and no work.
b Any contraception includes any modern (condom, birth control pills, spermicide, injectables, IUD, sterilization, Norplant) or traditional (abstinence, rhythm or
calendar method) method.
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violence-related research (Fontes, 2004). All exposure and outcome
measures were based on respondent self-reports. Violence-related
questions were adapted from the Conflict Tactics Scale (Straus, 1979)
and ask about specific forms of violence rather than asking about
“abuse” or “rape” more generally in keeping with WHO recommenda-
tions on best practice (García-Moreno et al., 2013). For example,
women were asked whether they were “pushed, slapped, or held down”
by their partner rather than whether they were physically abused (see
Appendix page 1 for the full list of IPV-related questions included in the
RCCS annual surveys). The study sample was limited to women who
reported having sex during the year prior to interview in at least one
survey and who completed at least two follow-up surveys. Further de-
tails on the formation of the study dataset are included in the Appendix
(page 1).
2.2. Statistical analyses
Our analytical objective was to estimate the causal effect of IPV on
women's contraceptive use. In consultation with subject matter experts,
we developed a directed acyclic graph (Glymour, 2017) to represent the
hypothesized causal relationship between IPV and women's contra-
ceptive use. In keeping with best practice for the development of IPT-
weighted estimators, we used potential common causes and variables
predictive of contraceptive use, rather than variables that predict IPV
exposure, to estimate the weight models (Lefebvre et al., 2008). The
analysis includes the following time-varying covariates: age; a compo-
site index of household wealth (see Appendix page 1 for a description of
the estimation of this variable); occupation; relationship status; part-
ner's occupation; fertility intentions; result of the previous pregnancy;
whether the respondent is actively trying to become pregnant; number
of sex partners in the last year; gravidity (see Appendix page 1 for a
description of how this variable was estimated from the data); and
current pregnancy status. Time-fixed covariates were: age at first sex or
marriage, whichever occurred first; baseline measures of education and
religion; and tribal affiliation.
Because women face various social and economic barriers when
accessing different forms of contraception, we estimated the effect of
each form of IPV on different contraceptive outcomes, including: 1)
condom use at last sex versus no condom use at last sex; 2) current use
of any modern method (condom, birth control pills, spermicide,
Fig. 2. The relative risk of different forms of women's contraceptive use by prior year experience of intimate partner violence (N=7923; 23,886 person-years of
follow-up).
IPV= intimate partner violence.
Modern contraceptive methods include (condom, birth control pills, spermicide, injectables, IUD, sterilization, Norplant). Partner dependent methods include:
condoms, abstinence, rhythm or calendar method; non-partner dependent methods include: birth control pills, spermicide, injectables, IUD, lactational amenorrhea,
herbs and other traditional medicines, sterilization, Norplant or no method. Unweighted regression is adjusted for all time-fixed (religion; tribal affiliation; education;
age at first sex or marriage) and lagged time-varying (age category; household wealth quintile; occupation; relationship status; partner's occupation; gravidity;
fertility intentions; result of the previous pregnancy; whether the respondent is actively trying to become pregnant; number of sex partners in the last year; and
pregnancy status) confounders and for lagged values of both the type of IPV that is classified as the exposure in that model and the other forms of IPV. Marginal
structural model is weighted using inverse probability of treatment weights, estimated separately for each exposure, and adjusted for time-fixed confounders.
Standard errors adjusted for loss of information due to repeat measures within individuals over time.
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injectables, IUD, sterilization, Norplant) versus current use of a tradi-
tional method or no contraceptive method; 3) current use of a partner
dependent method (condom; abstinence; rhythm or calendar method)
versus methods that do not necessarily require negotiation with one's
partner (birth control pills, spermicide, injectables, IUD, lactational
amenorrhea, herbs and other traditional medicines, sterilization,
Norplant) or no method; and 4) any method versus no method. Among
contraceptors, we looked at the relation between IPV and 1) current use
of a long-acting and permanent (LAPM; IUD, sterilization, Norplant)
versus a short-term modern contraceptive method (STM); 2) the use of a
hidden method (injectables) versus another modern or traditional
method; and 3) the use of a hidden method versus another modern
method. Respondents could report the use of multiple contraceptive
methods; there were 60 instances where women reported concurrent
use of more than one modern method. Please see Appendix pages 1–2
for a description of how multiple methods were classified.
Prior studies indicate that women's early experience of forced sex is
associated with their later life experience of IPV (Kouyoumdjian et al.,
2013b) and may be associated with contraceptive use. Because parti-
cipants' report of forced first sex was not measured for women who
participated in survey waves 7 and 8, we did not include this covariate
in our main models, but did conduct a sensitivity analysis to assess the
change in estimates with the inclusion of this variable (Appendix Table
A.15).
2.3. Application of marginal structural models
We estimated the average treatment effect, the average effect on
women's contraceptive use of moving the entire population from ex-
periencing IPV over the last year to not experiencing IPV over that year.
Given that odds ratios estimated using logistic regression overestimate
the risk of prevalent outcomes (McNutt et al., 2003), like contraceptive
use in this population, we used log Poisson regression (Zou, 2004) to
estimate the relative risk (RR) of each outcome. We regressed each
outcome on respondents' experience of IPV since the last visit and on
time-fixed baseline covariates. Our outcome models were weighted
using separate IPTWs for each form of IPV; standard errors were ad-
justed to account for the correlation of observations within individuals
over time (see Appendix pages 9–26 for a full description and evalua-
tion of the weight models). MSMs estimated using IPTWs can be used to
Fig. 3. The relative risk of different forms of women's contraceptive use by prior year experience of intimate partner violence, among contraceptors (N=5382;
11,726 person-years of follow-up).
IPV= intimate partner violence, LAPM= long-acting and permanent methods; STM= short-term methods.
Long-acting and permanent methods include: IUD, sterilization, Norplant; short-term methods include: condom, birth control pills, spermicide, injectables. Modern
contraceptive methods include: condom, birth control pills, spermicide, injectables, IUD, sterilization, Norplant; Hidden methods include: injectables, Norplant.
Traditional methods include: abstinence, rhythm or calendar method, lactational amenorrhea, herbs and other traditional medicines. Unweighted regression is
adjusted for all time-fixed (religion; tribal affiliation; education; age at first sex or marriage) and lagged time-varying (age category; household wealth quintile;
occupation; relationship status; partner's occupation; gravidity; fertility intentions; result of the previous pregnancy; whether the respondent is actively trying to
become pregnant; number of sex partners in the last year; and pregnancy status) confounders and for lagged values of both the type of IPV that is classified as the
exposure in that model and the other forms of IPV. Marginal structural model is weighted using inverse probability of treatment weights, estimated separately for
each exposure, and adjusted for time-fixed confounders. All standard errors adjusted for loss of information due to repeat measures within individuals over time.
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account for time-varying confounding assuming positivity, exchange-
ability, no unmeasured confounding, and no misspecification of the
model used to estimate the weights (Hernán et al., 2001). We in-
vestigated potential positivity violations by reviewing the mean of the
stabilized IPTWs (Cole and Hernán, 2008) (Appendix Fig. A3) and by
comparing the distribution of the propensity scores for women who did
and did not experience prior-year IPV (Appendix Figure A.4). All ana-
lyses were conducted with Stata SE version 13.1 (StataCorp LP, College
Station Texas).
3. Results
Fig. 1 describes the study sample. After removing observations
where the exposure was not recorded (7% of observations), less than
1% of data were missing values for measured confounders and these
observations were excluded from the analysis. The dataset used to es-
timate the relation between IPV and condom use at last sex included
23,463 observations from 7760 participants aged 15–52 interviewed at
waves 9–15. Because pregnant women were not asked about their
current contraceptive use, the sample used to estimate the relation
between IPV and the current contraceptive use was limited to the
23,886 observations from women who were not pregnant at the time of
survey (N=7923 women).
Select baseline characteristics are presented in Table 1 (see
Appendix Table A1 for descriptive statistics for all covariates). On
average, participants completed three visits. IPV was prevalent in this
sample, with 29% of women reporting any form of prior year IPV.
Emotional IPV was the most common form of violence (24%). Sexual
IPV was reported by 14% of women. Differences in women's experience
of IPV across levels of age, relationship status, pregnancy intentions,
and sexual behavior highlight the importance of controlling for these
confounders in the analysis.
3.1. Relation between intimate partner violence and contraceptive use
Fig. 2 presents the estimated relative risk (RR) for the relation be-
tween the different forms of IPV and the three contraceptive outcomes
for the bivariate, unweighted, and IPT-weighted regression models.
Confidence intervals for the weighted and unweighted regression esti-
mates overlap, which indicates that the weighted and unweighted es-
timates are quite similar.
Women who experienced any of the forms of IPV measured in the
Rakai cohort (emotional, physical, or sexual) were less likely to report
condom use at last sex. In the weighted model, women who experienced
any form of IPV during the year prior to interview were 20% less likely
to use a condom at last sex than women who did not experience IPV
during that year (95% CI: 0.12, 0.26). Women who experienced any
type of IPV were 27% less likely to report current use of a partner-
dependent method (95% CI: 0.20, 0.33), which suggests that women in
violent relationships may choose or be forced to use contraceptive
methods that do not require negotiation with their male partner. There
was no association between women's experience of IPV in the last year
and current use of modern contraception or the use of any method
(Appendix Table A.2; Fig. A1). The effect of IPV on contraceptive use is
constant across different forms of IPV. For example, women who ex-
perienced prior-year emotional IPV were 28% less likely (95% CI: 0.20,
0.34) and women who experienced sexual IPV were 21% less likely
(95% CI: 0.11, 0.30) to use a partner-dependent method than women
who did not.
3.2. Relation between intimate partner violence and contraceptive use,
among contraceptors
Fig. 3 presents the estimated RRs for the relation between each form
of IPV and contraceptive outcomes, among contraceptors. Among users
of modern methods, women who experienced any form of prior year
IPV were 24% more likely to adopt a LAPM than women who did not
(95% CI: 1.07, 1.44). Among women who reported current use of any
form of modern contraception, women who experienced any form of
IPV over the last year were 13% more likely to use a hidden contra-
ceptive method (95% CI: 1.08, 1.18). Point estimates corresponding to
Figs. 2 and 3 are presented in Appendix Tables A.3 and A.4.
Because we did not find substantial differences between the esti-
mates from weighted and unweighted models, we used unweighted
models to estimate the relation between the duration of IPV and the
predicted probability of women's use of each of the contraceptive out-
comes assessed earlier. We did not find a relation between IPV duration,
as estimated by the proportion of visits that women reported IPV, and
contraceptive outcomes. We present graphs and point estimates for the
duration models in the Appendix (Figures A.6 & A.7; Table A.16).
4. Discussion
Previous longitudinal studies suggest that IPV is associated with
reduced condom use (El-Bassel et al., 2005; Kacanek et al., 2013;
Stephenson et al., 2013; Van Horne, Wiemann, Berenson, Horwitz and
Volk, 2009). We found that all forms of IPV were associated with de-
creased use of condoms and of partner-dependent contraceptive
methods and increased use of hidden contraceptive methods. Among
users of modern contraception, women who experienced IPV were more
likely to use LAPM rather than short-term methods. Estimates from
MSMs were not different from estimates from traditional regression,
which suggests that controlling for potential confounders that were
hypothesized to be affected by prior levels of exposure (i.e. gravidity,
the result of the previous pregnancy, fertility intentions) did not bias
results in this sample because IPV was not a strong predictor of these
covariates. In keeping with a recent systematic review that identified
the classification of contraceptive methods as a source of heterogeneity
in the pooled estimates (Maxwell et al., 2015), we found that the
magnitude and direction of the relation between IPV and contraceptive
use varied across classes of contraceptive methods.
This analysis has a number of strengths. Previous studies have es-
timated the prevalence of IPV (Koenig et al., 2003; Kouyoumdjian et al.,
2013b) and the relation between IPV and other reproductive health-
related outcomes, including HIV, within the Rakai cohort (Chang et al.,
2016; Kouyoumdjian et al., 2013a,b) however, the effect of IPV on
women's contraceptive use has not been previously investigated. The
RCCS collected rich, time-varying data on important predictors of
contraceptive use which allowed us to account for the multidimensional
nature of pregnancy intentions by including measures of both inten-
tions and timing in our models (Santelli et al., 2009). There is some
disagreement about how to control for forms of IPV other than the type
of IPV, which is classified as the exposure in a given analysis. While
previous studies have compared women who experience each form of
IPV to women who experience no forms of IPV (Durevall and Lindskog,
2015), we avoided the selection involved in this comparison by con-
trolling for the potentially confounding effect of women's prior ex-
perience of other forms of IPV.
This analysis has some limitations. Because women who are re-
tained for at least three surveys (a baseline and two follow-up surveys)
may be less likely to experience IPV than women who complete fewer
surveys, limiting our sample to these women may introduce selection
bias, which would attenuate our estimates of the relation between IPV
and contraceptive use. Evidence suggests that the health effects of IPV
are related to the frequency and severity of IPV and to the presence of
male-controlling behaviors (Durevall and Lindskog, 2015). Our esti-
mate of the duration of IPV was based on the proportion of visits that
women reported prior-year IPV so women who reported IPV at two
visits were classified as having the same level of the exposure as women
who reported IPV at all seven visits, a form of measurement bias. The
frequency of IPV during the last year was not measured at all survey
waves and male controlling behaviors were not assessed in this cohort
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so we were not able to address whether these factors modified the effect
of IPV on women's contraceptive use. The RCCS is based in a rural
district in southern Uganda; findings from this study may not be gen-
eralizable to other populations.
4.1. Mechanism through which intimate partner violence affects
contraceptive use
Understanding how IPV affects condom use has important im-
plications for preventing unwanted or mistimed pregnancy and for the
prevention of HIV and other sexually transmitted infections (STIs).
While we did not explore the relative importance of different pathways
between IPV and condom use in this analysis, we address some of the
potential explanations for the relation here with the caveat that much of
the research on behavioral constructs like sexual relationship power
and relationship dynamics has been conducted in small, highly selected
populations in high income countries (Bonacquisti and Geller, 2013)
and may not be applicable to the Rakai context.
There are several competing hypotheses for the causal mechanism
between IPV and reduced condom use. Self-efficacy is an important
determinant of condom use (Baele et al., 2001) that may be affected by
IPV (Hung et al., 2012). Women and girls who do not feel comfortable
negotiating condom use may choose not to or be less successful in doing
so. A number of studies suggest that IPV is associated with reduced self-
efficacy for negotiating condom use. Some studies suggest that an im-
balance in relationship power, defined as “the extent to which one
person can influence and control their partner's behavior and dominate
decision-making within the dyad” (McGrane Minton et al., 2016) may
be the pathway through which IPV affects condom use, either instead of
or in addition to reduced condom self-efficacy (Bonacquisti and Geller,
2013). An alternative hypothesis is that IPV is a marker for male con-
trolling behaviors and that a woman's male partner may try to regulate
her fertility (Hung et al., 2012; Miller et al., 2011; Moore et al., 2010), a
construct called reproductive coercion or reproductive control
(Silverman and Raj, 2014). Another hypothesis is that women may be
less able to use condoms because they fear violent consequences
(Bonacquisti and Geller, 2013; McGrane Minton et al., 2016). Within a
relationship with a subtext of violence, pregnant women may prioritize
the safety of their unborn fetus over the risk of violence associated with
negotiating condom use (Hatcher et al., 2014).
The relation between IPV and contraceptive use may be a proxy for
other individual- or community-level exposures. Additional studies
highlight the importance of community-level determinants of contra-
ceptive use, including: community-level stigma, unequal gender norms,
or structural barriers to condom use (Dunkle and Decker, 2013;
Shannon et al., 2015). For example, the criminalization of sex work
may limit condom access because, within a restrictive legal environ-
ment, women and girls who exchange sex for money or gifts may
prioritize their immediate safety or food or housing security over per-
ceived HIV risk (Dunkle and Decker, 2013). Gender inequities can re-
sult in economic or social relationship dependence and contribute to
the power imbalance within relationships or prevent women from
leaving the abusive partnership (McGrane Minton et al., 2016). Lastly,
women may choose not to use condoms because of the perceived ex-
clusivity of the relationship (Bonacquisti and Geller, 2013) or because
they prefer unprotected sex (McGrane Minton et al., 2016). Future re-
search is should explore the relative importance of these pathways of
influence in Uganda and in other low-and-middle-income countries.
5. Conclusion
Defensible estimates of the impact of IPV on women's contraceptive
use are central to understanding the global burden of IPV and to closing
the gaps in contraceptive coverage that are a central target of the global
initiative to ensure access to contraception, Family Planning 2020
(http://www.familyplanning2020.org/). Our results suggest that
women who experience IPV are less likely to use condoms than women
who do not and that the magnitude and direction of the relation be-
tween IPV and contraceptive use depends on how contraception is de-
fined. Understanding how IPV affects women's contraceptive use has
important implications for ensuring that contraceptive access and HIV-
prevention programs can better meet the needs of women who ex-
perience IPV. Future studies should consider assessing how male con-
trolling behaviors and the frequency and severity of IPV modify the
relation between IPV and contraceptive use.
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